首页> 外文期刊>Modern Pathology >Histopathologic findings associated with APOL1 risk variants in chronic kidney disease
【24h】

Histopathologic findings associated with APOL1 risk variants in chronic kidney disease

机译:慢性肾脏疾病中与APOL1风险变异有关的组织病理学发现

获取原文
           

摘要

The effects of nephropathy risk variants in the apolipoprotein L1 gene (APOL1) on renal histopathology in African Americans with arterionephrosclerosis or putative ‘hypertension-associated’ nephropathy are unknown. APOL1 genotype–phenotype correlations were performed in a blinded manner from renal biopsies in 196 self-reported African Americans with arterionephrosclerosis on kidney biopsy at a large national nephropathology practice. Subjects had chronic kidney disease without nephrotic syndrome. A discovery analysis compared histopathologic changes in the glomerular and tubulointerstitial compartments in 58 subjects with 2 versus 56 subjects with 0 APOL1 risk variants. Validation was performed in biopsies from 82 additional subjects with 0, 1, and 2 risk variants. Two risk variant versus zero risk variant group genotype associations and subphenotypes were assessed by χ2 analyses. ANOVA compared means of continuous variables. In discovery analyses, significantly less obsolescent glomerulosclerosis, more (solidified and disappearing) glomerulosclerosis, more thyroidization-type tubular atrophy, and more microcystic tubular dilatation were seen in patients with two versus zero APOL1 risk alleles. Greater degrees of arteriosclerosis were present in those with zero risk alleles. Segmental glomerulosclerosis did not differ significantly between groups. Presence of two of the following discriminatory histopathologic findings from discovery, that is, APOL1 risk alleles in the validation phase. African Americans with arterionephrosclerosis who possess two APOL1 risk variants more often lack obsolescent glomerulosclerosis and have greater degrees of (solidified and disappearing) glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilation than patients with fewer than two risk variants. These findings support involvement of multiple cell types in subnephrotic forms of APOL1-associated nephropathy, particularly renal tubule cells with resultant tubulointerstitial disease.
机译:载脂蛋白L1基因(APOL1)中肾病风险变异对非裔美国人患有动脉硬化性肾病或推定的“高血压相关性”肾病的肾脏组织病理学影响尚不清楚。在一个大型的国家肾脏病理学实践中,以盲法从196名自我报告的患有动脉硬化性肾病的非洲裔美国人的肾脏活检中以肾脏活检的方式进行了APOL1基因型与表型的相关性。受试者患有慢性肾脏疾病而没有肾病综合征。发现分析比较了58名2个受试者与56名APOL1风险变异型受试者的肾小球和肾小管间质腔室的组织病理学变化。在活检中对另外82位具有0、1和2个风险变量的受试者进行了验证。通过χ2分析评估了两种风险变体与零风险变体组的基因型关联和亚表型。方差分析比较了连续变量的平均值。在发现分析中,在两个APOL1风险等位基因相对于零个APOL1等位基因等位基因患者中,发现肾小球性硬化症更少(更多)(凝固和消失),甲状腺素化型肾小管萎缩和微囊性肾小管扩张更多。等位基因风险为零的人群存在较高的动脉硬化程度。两组之间的节段性肾小球硬化没有显着差异。从发现中发现以下两个有区别的组织病理学发现,即在验证阶段存在APOL1风险等位基因。与具有两种以下风险变异的患者相比,拥有两种APOL1风险变异的非裔美国人更经常缺乏陈旧性肾小球硬化,并具有更大程度的(巩固和消失)肾小球硬化,甲状腺化型肾小管萎缩和微囊性肾小管扩张。这些发现支持多种细胞类型参与亚POL1型相关性肾病的亚肾病形式,尤其是肾小管细胞伴有肾小管间质性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号